Furthermore, it has been reported that hypoxia‐inducible factor prolyl hydroxylase, a new medication for treating anemia, improved BNP in patients with HF,43 and these therapeutic medications may provide new perspectives on treating anemia in patients with HF. This evidence concerns the gene NPPB and anemia.